Effects of Modified Ultrafiltration on Thromboelastographic Profile after Pediatric Cardiac Surgery

Umair Abbas1, Rohit S Loomba1, Cynthia Urbas1

  • 1Advocate Children's Hospital, Oak Lawn, Illinois.

Insights

Modified ultrafiltration (MUF) after pediatric cardiopulmonary bypass (CPB) worsens coagulation. Protamine administration reversed these negative effects, suggesting MUF may not benefit coagulation in neonates undergoing cardiac surgery.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Hematology

Background:

  • Modified ultrafiltration (MUF) is employed post-pediatric cardiopulmonary bypass (CPB) to reduce transfusions and potentially improve outcomes.
  • Its effects on coagulation status and thromboelastography (TEG) parameters in neonates remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of MUF on coagulation factors and TEG parameters in infants undergoing cardiac surgery.
  • To determine if MUF influences thromboelastography (TEG) measurements in neonates post-pediatric cardiopulmonary bypass (CPB).

Main Methods:

  • Prospective enrollment of pediatric patients (<6 months) undergoing cardiac surgery.
  • Thromboelastography (TEG) analysis performed before MUF, after MUF, and after protamine administration.
  • Paired t tests used to compare TEG parameters at different time points.

Main Results:

  • MUF significantly worsened TEG parameters (R, α, MA) compared to pre-MUF values.
  • Coagulation parameters significantly improved after protamine administration compared to post-MUF.
  • Greater fluid removal during MUF correlated with worse post-MUF and post-protamine TEG values.

Conclusions:

  • Modified ultrafiltration (MUF) negatively impacts coagulation parameters in neonates after pediatric cardiopulmonary bypass (CPB).
  • The adverse effects of MUF on coagulation are reversible with protamine administration.
  • These findings question the routine use of MUF for improving coagulation in this patient population.